Naoto Takahashi

Dr. Naoto Takahashi


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
ASAkira Sasaki
Akira Sasaki
AUAkira Umemura
Akira Umemura
IKIshida Kazuyuki
Ishida Kazuyuki
NTNaoto Takahashi
Naoto Takahashi
HNHaruka Nikai
Haruka Nikai
TSTamotsu Sugai
Tamotsu Sugai
Practitioners routinely perform intraoperative liver biopsies during laparoscopic sleeve gastrectomy (LSG) to evaluate nonalcoholic fatty liver disease (NAFLD). In some patients, hepatocyte ballooning, inflammation, and fibrosis without steatosis are observed, even in the absence of other etiologies. We call this finding indeterminable nonalcoholic steatohepatitis (Ind-NASH). In this study, we clarified the prevalence, as well as histopathological and clinical features, of Ind-NASH through intraoperative liver biopsy in Japanese patients presenting with severe obesity. We enrolled 63 patients who had undergone LSG and intraoperative liver biopsy. In patients diagnosed with histopathological NASH, we performed protocol liver biopsies at 6 and 12 months after LSG. We statistically analyzed these histopathological findings and clinical parameters and found the prevalence rate of Ind-NASH discovered through intraoperative biopsy to be 15.9%. Protocol liver biopsy also revealed that Ind-NASH was an intermediate condition between NASH and normal liver. The clinical features of patients with Ind-NASH are a higher body weight compared to NASH (134.9 kg vs. 114.7 kg; p = 0.0245), stronger insulin resistance compared to nonalcoholic fatty liver (homeostasis model assessment–insulin resistance: 7.1 vs. 4.9; p = 0.0188), and mild liver dysfunction compared to NASH. Patients with Ind-NASH observed positive weight-loss effects from a preoperative diet compared to the postoperative course (percentage total weight loss: 32.0% vs. 26.7%; p < 0.0001). Patients with Ind-NASH may also be good candidates for metabolic surgery owing to their good treatment response; therefore, efforts should be made by specialists in the near future to deeply discuss and define Ind-NASH.

14 November 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
NTNaoto Takahashi
Naoto Takahashi
ASAkira Sasaki
Akira Sasaki
AUAkira Umemura
Akira Umemura
TSTamotsu Sugai
Tamotsu Sugai
KKKeisuke Kakisaka
Keisuke Kakisaka
IYISHIGAKI YASUSHI
ISHIGAKI YASUSHI
The prevalence of nonalcoholic steatohepatitis (NASH) in severely obese Japanese patients is extremely high. However, there are currently no methods other than liver biopsy to assess hepatic steatosis and fibrosis. The purpose of this study was to comprehensively analyze changes in fatty acid (FA) and serum-free fatty acid (FFA) metabolism in severely obese Japanese patients to determine whether these could be surrogate markers. In this study, we enrolled 20 Japanese patients who underwent laparoscopic sleeve gastrectomy (LSG) for severe obesity and intraoperative liver biopsy. Serum FFAs were analyzed with liquid chromatography-mass spectrometry, and FAs in liver tissue were assessed using matrix-assisted laser desorption/ionization-imaging mass spectrometry to determine FAs that may be indicative of a positive NASH diagnosis. All patients showed significant weight loss and metabolic improvement following LSG. Regarding weight loss and metabolic improvement indices, 23 FFAs showed significant correlations with the baseline data. Narrowing down the phospholipids to commonly detected FAs detected in liver tissue, PC(18:1e_20:4) was significantly changed in the NASH group, suggesting that it could be used as a surrogate marker for NASH diagnosis. The results suggest that specific postoperative changes in blood phospholipids could be used as surrogate markers for NASH treatment.

1 January 2025 in Case Reports in Gastrointestinal Medicine
Verified
Journal Article
Open access
NTNaoto Takahashi
Naoto Takahashi
HFHitoshi Fujii
Hitoshi Fujii
TITomohiro Iwasa
Tomohiro Iwasa
YKYuka Koizumi
Yuka Koizumi
YMYukihiro Minagawa
Yukihiro Minagawa
CTChihiro Tono
Chihiro Tono
Background: Human epidermal growth factor receptor 2 (HER2)‐positive gastric cancer accounts for approximately 15% of gastric cancer cases. Trastuzumab (Trz), a monoclonal antibody targeting HER2, has been shown to improve overall survival when combined with chemotherapy. However, while Trz‐induced cardiotoxicity (TIC) is a well‐recognized adverse effect in breast cancer chemotherapy, reports on its occurrence in gastric cancer treatment remain limited. Case Presentation: An 80‐year‐old Japanese male with HER2‐positive advanced gastric cancer (cStage III) developed ventricular arrhythmia and heart failure during postoperative chemotherapy with the Trz + SOX regimen (Trz, oxaliplatin, and TS‐1). The patient initially underwent distal gastrectomy with D1+ lymphadenectomy for anemia and pyloric stenosis. Metastasis to the #8a lymph node (anterior superior lymph node of the common hepatic artery) and pancreatic invasion via lymph nodes were treated with two cycles of the Trz + SOX regimen, leading to a partial response. However, after the 11th cycle, he developed ventricular tachycardia and heart failure. Cardiac imaging and laboratory findings revealed no coronary artery disease or structural abnormalities, suggesting TIC as the underlying cause. Antiarrhythmic therapy with pharmacological agents led to symptom resolution, and no recurrence of arrhythmia or heart failure was observed. Discussion: This case highlights the potential cardiotoxicity associated with nonanthracycline‐based Trz regimens for gastric cancer. Pathophysiologically, HER2 signaling inhibition in cardiomyocytes may impair stress responses and repair mechanisms. The patient’s advanced age, history of hypertension and anemia, and cumulative exposure to chemotherapy may have contributed to increased cardiac vulnerability. Careful monitoring of cardiac function is essential in elderly and comorbid patients undergoing Trz‐based therapy for gastric cancer to mitigate the risk of cardiotoxicity. Conclusion: Trz‐based chemotherapy for HER2‐positive gastric cancer, even without anthracyclines, may pose a risk of cardiotoxicity, particularly in elderly or comorbid patients. Further research is warranted to elucidate underlying mechanisms and optimize monitoring and prevention strategies in this population.

1 January 2026 in Case Reports in Gastrointestinal Medicine
Verified
Journal Article
Open access
NTNaoto Takahashi
Naoto Takahashi
HFHitoshi Fujii
Hitoshi Fujii
CTChihiro Tono
Chihiro Tono
HNHaruka Nikai
Haruka Nikai
RFRyosuke Fujisawa
Ryosuke Fujisawa
SBShigeaki Baba
Shigeaki Baba
Background: Catheter ablation has become a standard therapeutic strategy for atrial fibrillation (AF), with pulmonary vein isolation (PVI) commonly achieved using cryoballoon ablation (CBA) or radiofrequency ablation (RFA). Although CBA is associated with fewer severe complications and shorter procedural times, collateral injury to adjacent structures, such as the esophagus and periesophageal vagal plexus, can occasionally occur. Gastric hypomotility (GH) secondary to vagal nerve injury is a rare but clinically important complication that may present with nonspecific gastrointestinal symptoms. Case Presentation: A 46‐year‐old woman with no history of smoking or alcohol use was diagnosed with tachycardia‐induced cardiomyopathy and heart failure due to AF. After stabilization, she underwent PVI using second‐generation CBA at another institution. Two days postprocedure, she developed abdominal pain, nausea, and upper abdominal distension. Physical examination revealed mild epigastric distension without tenderness. Laboratory findings were unremarkable except for mild elevation in blood urea nitrogen and C‐reactive protein. Abdominal radiography and CT demonstrated marked gastric dilatation without mechanical obstruction. Upper gastrointestinal endoscopy showed retained food residue in the stomach but no structural lesions. Based on these findings, postablation GH due to periesophageal vagal nerve injury was diagnosed. Treatment and Outcome: Conservative outpatient management was initiated, including mosapride citrate (15 mg/day in divided doses) and a low‐fat, low‐fiber diet. The patient’s symptoms gradually improved within one month, and follow‐up imaging at three months confirmed complete resolution of gastric dilatation. No recurrence was observed during six months of follow‐up. Conclusion: GH following CBA for AF is a rare but notable complication caused by vagal nerve injury. Early recognition through clinical and radiologic assessment allows effective conservative management, avoiding unnecessary invasive procedures. This case highlights the importance of multidisciplinary awareness and prompt intervention in achieving favorable outcomes.

1 July 2025 in The Japanese Journal of Gastroenterological Surgery
Verified
Journal Article
Open access
PDF file
NTNaoto Takahashi
Naoto Takahashi
SSShusaku Sasaki
Shusaku Sasaki
HFHitoshi Fujii
Hitoshi Fujii
HSHiroaki Shimada
Hiroaki Shimada
TITomohiro Iwasa
Tomohiro Iwasa
CTChihiro Tono
Chihiro Tono
症例は73歳の男性で,下部消化管内視鏡検査にて直腸Raに半周性の3型腫瘍を認め,生検で印環細胞癌と診断された.直腸癌cT3N1bM0,cStage IIIbに対して腹腔鏡下低位前方切除術およびD3郭清を施行した.pT3N2aM0,pStage IIIcに対して術後補助化学療法としてmFOLFOX6を12コース施行した.術後1年3か月間,無再発で経過したが,急性発症した腰痛および播種性血管内凝固症候群(disseminated intravascular coagulation syndrome;以下,DICと略記)の治療のため入院した.MRI,骨シンチグラフィにより直腸癌の多発骨転移再発,播種性骨髄癌症の診断となった.DICに対する治療を開始したものの全身状態の改善は乏しく,入院後46日目に循環不全のため死亡した.直腸癌の播種性骨髄癌症はまれな疾患であり,極めて予後不良である.発症後に化学療法を行って生存を得た症例報告もあるが,発症時に全身状態が不良であることが多く,症例に応じた治療内容の検討が必要である.